Advice and Guidance on all aspects of the management of hyperlipidaemia is available at UHBW
Advice & Guidance requests are not processed by the Referral Service. All requests should be submitted directly to the Lipid Advice & Guidance Service using e-Referral.
Advice & Guidance can be provided on:
Please note that this service is NOT for Endocrinology advice and any such requests will be returned.
To enable the consultants to give the best advice possible please consider the following points:
Please see the relevant information below on how to make an advice request via eRS. Advice requests should ideally be typed into the free text window of the advice request body on e-RS rather than attaching a separate letter or Word document. If you attach a Clinical Information Summary, please ensure it is named this, so that clinicians at secondary care can opt to look at it if they wish to turn the request into a referral.
UHB - Lipid A&G Guidance document
Please process through eRS bypassing the Referral Service.
Priority - Routine (not urgent or 2WW)
Specialty - Endocrinology & Metabolic Medicine
Clinic - Lipid Disorders
The e-Referrals advice and guidance cannot be used for:
For urgent advice, telephone Dr Eloise Willis (0117 342 9288), Dr Andrew Day (0117 342 7767) (UHBW, Bristol) or Dr Wycliffe Mbagaya (01934 647019) (UHBW, Weston) or via the Lipid Clinic Secretaries on 0117 342 7708.
Please see below the clinical pathways (designed by UHBW Biochemists) for patients who may be identified by the tools that are on offer to practices. They cover two clinical areas:
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.